Sign up to save your podcasts
Or
Share Thursday, October 19, 2023
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Thursday, October 19, 2023
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Gist Healthcare Daily
4.8
134134 ratings
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
More shows like The Gist Healthcare Podcast
View all
Marketplace Morning Report
890 Listeners
Marketplace
8,649 Listeners
Slate Money
1,011 Listeners
Pivot
9,140 Listeners
Pod Save America
86,615 Listeners
The Daily
111,827 Listeners
KFF Health News' 'What the Health?'
478 Listeners
Stay Tuned with Preet
32,386 Listeners
An Arm and a Leg
1,083 Listeners
Becker’s Healthcare Podcast
184 Listeners
Fiction - Comedy Fiction
6,447 Listeners
America Dissected
4,476 Listeners
Tradeoffs
391 Listeners
Raising Health
147 Listeners
The Ezra Klein Show
15,237 Listeners